%0 Journal Article
%A Delaidelli, Alberto
%A Dunham, Christopher
%A Santi, Mariarita
%A Negri, Gian Luca
%A Triscott, Joanna
%A Zheludkova, Olga
%A Golanov, Andrey
%A Ryzhova, Marina
%A Okonechnikov, Konstantin
%A Schrimpf, Daniel
%A Stichel, Damian
%A Ellison, David W
%A von Deimling, Andreas
%A Kool, Marcel
%A Pfister, Stefan
%A Ramaswamy, Vijay
%A Korshunov, Andrey
%A Taylor, Michael D
%A Sorensen, Poul H
%T Clinically Tractable Outcome Prediction of non-WNT/non-SHH Medulloblastoma Based on TPD52 Immunohistochemistry in a Multicohort Study.
%J Clinical cancer research
%V 28
%N 1
%@ 1557-3265
%C Philadelphia, Pa. [u.a.]
%I AACR
%M DKFZ-2021-02359
%P 116-128
%D 2022
%Z 2022 Jan 1;28(1):116-128
%X International consensus and the 2021 WHO classification recognize eight molecular subgroups among non-WNT/non-SHH (Group 3/4) medulloblastoma, representing  60
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:34702771
%R 10.1158/1078-0432.CCR-21-2057
%U https://inrepo02.dkfz.de/record/177225